Charles Atkinson

Array ( [id] => 6509059 [patent_doc_number] => 20020025918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'Methods of using helical peptides in plants' [patent_app_type] => new [patent_app_number] => 09/898576 [patent_app_country] => US [patent_app_date] => 2001-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9417 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20020025918.pdf [firstpage_image] =>[orig_patent_app_number] => 09898576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6838841 [patent_doc_number] => 20030036181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Peptide extended glycosylated polypeptides' [patent_app_type] => new [patent_app_number] => 09/896896 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 32418 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036181.pdf [firstpage_image] =>[orig_patent_app_number] => 09896896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688364 [patent_doc_number] => 20030032089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Isolated cocoon silk protein from simulium vittatum and nucleic acids encoding such protein' [patent_app_type] => new [patent_app_number] => 09/894916 [patent_app_country] => US [patent_app_date] => 2001-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3266 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032089.pdf [firstpage_image] =>[orig_patent_app_number] => 09894916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6621976 [patent_doc_number] => 20020065223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-30 [patent_title] => '33358, a novel human ankyrin family member and uses thereof' [patent_app_type] => new [patent_app_number] => 09/884870 [patent_app_country] => US [patent_app_date] => 2001-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 38574 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20020065223.pdf [firstpage_image] =>[orig_patent_app_number] => 09884870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1082978 [patent_doc_number] => 06833357 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-21 [patent_title] => 'Compositions and methods for modulating muscle cell and tissue contractility' [patent_app_type] => B2 [patent_app_number] => 09/880503 [patent_app_country] => US [patent_app_date] => 2001-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 26 [patent_no_of_words] => 29907 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/833/06833357.pdf [firstpage_image] =>[orig_patent_app_number] => 09880503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6378056 [patent_doc_number] => 20020119530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Method of increasing product expression through solute stress' [patent_app_type] => new [patent_app_number] => 09/867948 [patent_app_country] => US [patent_app_date] => 2001-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7800 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119530.pdf [firstpage_image] =>[orig_patent_app_number] => 09867948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6208455 [patent_doc_number] => 20020071873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'Homeopathic preparations' [patent_app_type] => new [patent_app_number] => 09/870132 [patent_app_country] => US [patent_app_date] => 2001-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8949 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20020071873.pdf [firstpage_image] =>[orig_patent_app_number] => 09870132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6336968 [patent_doc_number] => 20020199215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Novel toxins' [patent_app_type] => new [patent_app_number] => 09/858525 [patent_app_country] => US [patent_app_date] => 2001-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15571 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20020199215.pdf [firstpage_image] =>[orig_patent_app_number] => 09858525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 990784 [patent_doc_number] => 06919311 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-19 [patent_title] => 'Factor VII polypeptide having factor VII:C activity' [patent_app_type] => utility [patent_app_number] => 09/831679 [patent_app_country] => US [patent_app_date] => 2001-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11616 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/919/06919311.pdf [firstpage_image] =>[orig_patent_app_number] => 09831679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6291399 [patent_doc_number] => 20020055460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue' [patent_app_type] => new [patent_app_number] => 09/851738 [patent_app_country] => US [patent_app_date] => 2001-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5866 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055460.pdf [firstpage_image] =>[orig_patent_app_number] => 09851738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5999769 [patent_doc_number] => 20020028465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Novel molecules of the NBS/LRR protein family and uses thereof' [patent_app_type] => new [patent_app_number] => 09/848035 [patent_app_country] => US [patent_app_date] => 2001-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 52815 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028465.pdf [firstpage_image] =>[orig_patent_app_number] => 09848035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1050124 [patent_doc_number] => 06861403 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-01 [patent_title] => 'Method and device for improving protein stability and solubility' [patent_app_type] => utility [patent_app_number] => 09/848780 [patent_app_country] => US [patent_app_date] => 2001-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4109 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/861/06861403.pdf [firstpage_image] =>[orig_patent_app_number] => 09848780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5874567 [patent_doc_number] => 20020049156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Polyhudroxy glycopeptide derivatives' [patent_app_type] => new [patent_app_number] => 09/847061 [patent_app_country] => US [patent_app_date] => 2001-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16685 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049156.pdf [firstpage_image] =>[orig_patent_app_number] => 09847061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6131252 [patent_doc_number] => 20020077280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin' [patent_app_type] => new [patent_app_number] => 09/846893 [patent_app_country] => US [patent_app_date] => 2001-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16535 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077280.pdf [firstpage_image] =>[orig_patent_app_number] => 09846893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5789444 [patent_doc_number] => 20020161182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons' [patent_app_type] => new [patent_app_number] => 09/846345 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6324 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20020161182.pdf [firstpage_image] =>[orig_patent_app_number] => 09846345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5789449 [patent_doc_number] => 20020161185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Biopolymer marker indicative of disease state having a molecular weight of 1206 daltons' [patent_app_type] => new [patent_app_number] => 09/845725 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6308 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20020161185.pdf [firstpage_image] =>[orig_patent_app_number] => 09845725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5789446 [patent_doc_number] => 20020161183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons' [patent_app_type] => new [patent_app_number] => 09/846348 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6342 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20020161183.pdf [firstpage_image] =>[orig_patent_app_number] => 09846348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5789450 [patent_doc_number] => 20020161186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons' [patent_app_type] => new [patent_app_number] => 09/846349 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6326 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20020161186.pdf [firstpage_image] =>[orig_patent_app_number] => 09846349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1245865 [patent_doc_number] => 06677303 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-13 [patent_title] => 'Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons' [patent_app_type] => B2 [patent_app_number] => 09/846352 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6219 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677303.pdf [firstpage_image] =>[orig_patent_app_number] => 09846352 [rel_patent_id] =>[rel_patent_doc_number] =>)